We validated these flow cytometry results by immunohistochemical analysis, which demonstrated a consistently augmented infiltration of CD3+, CD4+, and CD8+ T cells within the tumor after siGsdmc treatment (Figure 8D,E). The gene discussed is CD8A; the disease is neoplasm.